Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Biomerica stock

Own Biomerica stock in just a few minutes.

Biomerica, Inc is a diagnostics & research business based in the US. Biomerica shares (BMRA) are listed on the NASDAQ and all prices are listed in US Dollars. Biomerica employs 65 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Biomerica

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BMRA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Biomerica share price

Use our graph to track the performance of BMRA stocks over time.

Biomerica shares at a glance

Information last updated 2021-04-30.
52-week range$4.22 - $12.75
50-day moving average $5.40
200-day moving average $6.08
Wall St. target price$10.88
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.26

Buy Biomerica shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Biomerica stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Biomerica financials

Revenue TTM $8.9 million
Gross profit TTM $1.8 million
Return on assets TTM -31.91%
Return on equity TTM -71.47%
Profit margin -61.56%
Book value $0.86
Market capitalisation $57.3 million

TTM: trailing 12 months

Shorting Biomerica shares

There are currently 1.0 million Biomerica shares held short by investors – that's known as Biomerica's "short interest". This figure is 11.1% up from 919,227 last month.

There are a few different ways that this level of interest in shorting Biomerica shares can be evaluated.

Biomerica's "short interest ratio" (SIR)

Biomerica's "short interest ratio" (SIR) is the quantity of Biomerica shares currently shorted divided by the average quantity of Biomerica shares traded daily (recently around 152441.94029851). Biomerica's SIR currently stands at 6.7. In other words for every 100,000 Biomerica shares traded daily on the market, roughly 6700 shares are currently held short.

However Biomerica's short interest can also be evaluated against the total number of Biomerica shares, or, against the total number of tradable Biomerica shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Biomerica's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Biomerica shares in existence, roughly 80 shares are currently held short) or 0.1004% of the tradable shares (for every 100,000 tradable Biomerica shares, roughly 100 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Biomerica.

Find out more about how you can short Biomerica stock.

Biomerica share dividends

We're not expecting Biomerica to pay a dividend over the next 12 months.

Have Biomerica's shares ever split?

Biomerica's shares were split on 6 April 2016.

Biomerica share price volatility

Over the last 12 months, Biomerica's shares have ranged in value from as little as $4.22 up to $12.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biomerica's is -0.7066. This would suggest that Biomerica's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Biomerica has bucked the trend.

Biomerica overview

Biomerica, Inc. , a biomedical technology company, together with its subsidiaries, develops, patents, manufactures, and markets diagnostic and therapeutic products or detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy that is designed to allow physicians to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms; Helicobacter pylori products; and develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site